Madeline King, PharmD, BCIDP is an infectious diseases PGY2 residency program director, and outpatient infectious diseases clinical pharmacist, Cooper University Hospital.
Influenza Vaccination With SARS-CoV-2 mRNA Booster Shots
November 23rd 2022Drs Jacinda Abdul-Mutakabbir, Madeline King, Rodney Rohde, and expert nurse practitioner Wendy Wright provide insight on receiving the influenza vaccine concurrently with the SARS-CoV-2 booster shot, and comment on data on immune responses from the Moderna and Pfizer/BioNTech vaccines.
Read More
Defining SARS-CoV-2 Bivalent Vaccines and Optimizing Protection Through Vaccination
November 16th 2022Wendy Wright, DNP, ANP-BC, FNP-BC, FAANP, FAAN, FNAP; Jacinda Abdul-Mutakabbir, PharmD; and Rodney E. Rohde, PhD, MS, SM(ASCP)CM, SVCM, MBCM, FACSc; review what encompasses a bivalent vaccine and give their perspective on how to communicate the role of the vaccine in optimizing protection for patients.
Read More
Evolution of SARS-CoV-2 Variants on Booster Shot Development and Formulations
November 11th 2022Rodney E. Rohde, PhD, MS, SM(ASCP)CM, SVCM, MBCM, FACSc, leads a discussion on the constant evolution of SARS-CoV-2 variants and the impact on vaccine and booster shot development and administration.
Read More
COVID-19 Booster Vaccination Protection Rates
November 11th 2022Jacinda Abdul-Mutakabbir, PharmD; Wendy Wright, DNP, ANP-BC, FNP-BC, FAANP, FAAN, FNAP; and Madeline King, PharmD, BCIDP, examine the efficacy and real-world implications of the COVID-19 booster shot in terms of vaccination protection rates.
Read More